STOCK TITAN

Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Akoya Biosciences (Nasdaq: AKYA) will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 9:45 a.m. PT. CEO Brian McKelligon is set to present the company's advancements in spatial biology, particularly its single-cell imaging solutions that enhance the understanding of biology and health through spatial phenotyping. A webcast of the event will be available on Akoya's investor website. Akoya aims to serve researchers across various fields, offering key platforms such as PhenoCycler™ and PhenoImager™.

Positive
  • None.
Negative
  • None.

MARLBOROUGH, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference.

Brian McKelligon, CEO, is scheduled to present on Wednesday, January 11th, 2023 at 9:45 a.m. PT.

A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com

Media Contact:
Christine Quern
(617) 650-8497
media@akoyabio.com


FAQ

When is Akoya Biosciences presenting at the J.P. Morgan Healthcare Conference?

Akoya Biosciences is scheduled to present on January 11, 2023, at 9:45 a.m. PT.

What is the focus of Akoya Biosciences at the conference?

Akoya Biosciences will focus on advancements in spatial biology and single-cell imaging solutions.

Where can I watch Akoya Biosciences' conference presentation?

The presentation can be viewed live or archived on Akoya's investor website.

What are the key platforms offered by Akoya Biosciences?

Akoya's key platforms include PhenoCycler™ and PhenoImager™.

What is Akoya Biosciences' mission?

Akoya's mission is to provide context to biology and human health through spatial phenotyping.

Akoya BioSciences, Inc.

NASDAQ:AKYA

AKYA Rankings

AKYA Latest News

AKYA Stock Data

117.96M
25.62M
11.09%
70.19%
3.24%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States of America
MARLBOROUGH